Swedbank’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $438M | Hold |
12,157,470
| – | – | 0.49% | 39 |
|
|
2025
Q1 | $378M | Sell |
12,157,470
-6,700
| -0.1% | -$209K | 0.5% | 44 |
|
|
2024
Q4 | $310M | Buy |
12,164,170
+1,136,800
| +10% | +$29M | 0.38% | 57 |
|
|
2024
Q3 | $312M | Buy |
11,027,370
+213,900
| +2% | +$6.05M | 0.4% | 55 |
|
|
2024
Q2 | $285M | Buy |
+10,813,470
| New | +$285M | 0.38% | 56 |
|
|
2024
Q1 | – | Sell |
-5,468,900
| Closed | -$154M | – | 687 |
|
|
2023
Q4 | $154M | Buy |
5,468,900
+1,517,000
| +38% | +$42.6M | 0.25% | 80 |
|
|
2023
Q3 | $107M | Buy |
3,951,900
+101,800
| +3% | +$2.76M | 0.19% | 101 |
|
|
2023
Q2 | $118M | Buy |
3,850,100
+795,155
| +26% | +$24.4M | 0.2% | 101 |
|
|
2023
Q1 | $110M | Buy |
3,054,945
+1,215,528
| +66% | +$43.8M | 0.22% | 98 |
|
|
2022
Q4 | $72.7M | Buy |
1,839,417
+448,500
| +32% | +$17.7M | 0.16% | 131 |
|
|
2022
Q3 | $55.9M | Buy |
1,390,917
+897,400
| +182% | +$36.1M | 0.13% | 145 |
|
|
2022
Q2 | $20.7M | Hold |
493,517
| – | – | 0.05% | 289 |
|
|
2022
Q1 | $19.2M | Hold |
493,517
| – | – | 0.04% | 338 |
|
|
2021
Q4 | $19.8M | Hold |
493,517
| – | – | 0.03% | 349 |
|
|
2021
Q3 | $17.8M | Buy |
493,517
+166,017
| +51% | +$6M | 0.03% | 368 |
|
|
2021
Q2 | $13.4M | Buy |
+327,500
| New | +$13.4M | 0.03% | 422 |
|